GALMED PHARMACEUTICALS LTD (GLMD) Stock Balance Sheet
NASDAQ:GLMD - Nasdaq - IL0011313900 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 9.72M | 2.86M | 2.02M | 2.88M | 6.95M | |||
| Marketable Securities | 7.42M | 9.78M | 11.77M | 31.93M | 43.94M | |||
| Receivables | 426.00K | 165.00K | 120.00K | 80.00K | 70.00K | |||
| Other Current Assets | 119.00K | 432.00K | 810.00K | 1.16M | 860.00K | |||
| Total Current Assets | 17.68M | 13.24M | 14.72M | 36.05M | 51.81M | |||
| Non-Current Assets | ||||||||
| PPE Net | 0.00 | 125.00K | 340.00K | 550.00K | 570.00K | |||
| Investments And Advances | 3.27M | 3.27M | 1.50M | N/A | N/A | |||
| Total Non-Current Assets | 3.27M | 3.39M | 1.84M | 560.00K | 570.00K | |||
| TOTAL ASSETS | 20.95M | 16.63M | 16.56M | 36.61M | 52.38M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | N/A | N/A | N/A | N/A | N/A | |||
| Accounts Payable | 1.34M | 1.88M | 2.56M | 4.87M | 7.05M | |||
| Other Current Liabilities | 1.17M | 871.00K | 530.00K | 1.01M | 970.00K | |||
| Total Current Liabilities | 2.51M | 2.75M | 3.09M | 5.88M | 8.01M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | 0.00 | 40.00K | 230.00K | 220.00K | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 50.00K | 230.00K | 220.00K | |||
| TOTAL LIABILITIES | 2.51M | 2.75M | 3.14M | 6.11M | 8.23M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -197.26M | -192.95M | -186.04M | -168.17M | -135.71M | |||
| Additional Paid In Capital | 215.37M | 207.08M | 200.14M | 198.77M | 179.53M | |||
| Common Shares | 665.00K | 209.00K | 70.00K | 70.00K | 60.00K | |||
| Shares Outstanding | 1.51M | 420.43K | 1.68M | 1.67M | 1.42M | |||
| Tangible Book Value per Share | 12.23 | 33.01 | 7.99 | 18.26 | 31.09 | |||
| Total Shareholders' Equity | 18.44M | 13.88M | 13.42M | 30.50M | 44.15M | |||
| TOTAL LIABILITIES AND EQUITY | 20.95M | 16.63M | 16.56M | 36.61M | 52.38M | |||
| Statistics | ||||||||
| Current Ratio | 7.03 | 4.81 | 4.76 | 6.13 | 6.47 | |||
| Return On Assets (ROA) | -30.19% | -41.57% | -107.91% | -88.69% | -54.93% | |||
| Return On Equity (ROE) | -34.30% | -49.80% | -133.16% | -106.46% | -65.16% | |||
All data in USD , ROIC based on taxRate of 0.21